logo
Select company
Select metric
0%Goodwill & Intangibles to Assets Ratio
VS
Market
-
Sector
-
Industry
-
History
-
$ 4.55Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 103.27M$ 00%
3/31/2025$ 117.01M$ 00%
12/31/2024$ 131.71M$ 00%
9/30/2024$ 140.44M$ 00%
6/30/2024$ 160.04M$ 00%
3/31/2024$ 150.29M$ 00%
12/31/2023$ 144.4M$ 00%
9/30/2023$ 158.64M$ 00%
6/30/2023$ 176.82M$ 00%
3/31/2023$ 191.22M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) Intang. to Assets stands at 0%.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average Intang. to Assets has been 0%.
  • The median Intang. to Assets for ARBUTUS BIOPHARMA CORP during this period was 0%
  • ARBUTUS BIOPHARMA CORP reached its highest Intang. to Assets over the past 5 years at 0%.
  • The lowest Intang. to Assets recorded by ARBUTUS BIOPHARMA CORP in the same timeframe 0%

ARBUTUS BIOPHARMA CORP's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
ZBIO : ZENAS BIOPHARMA INC 0%QURE : UNIQURE NV 17.26%NUVB : NUVATION BIO INC 1.88%VIR : VIR BIOTECHNOLOGY INC 2.09%BCYC : BICYCLE THERAPEUTICS PLC 0%IMNM : IMMUNOME INC 0%RLAY : RELAY THERAPEUTICS INC 0%CAPR : CAPRICOR THERAPEUTICS INC 0%ALMS : ALUMIS INC 8.34%TSHA : TAYSHA GENE THERAPIES INC 0%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for ARBUTUS BIOPHARMA CORP is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 131.1M ]
(=) Intang. to Assets [ 0% ]

ABUS - Goodwill & Intangibles to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.98% with a standard deviation of 6.09%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.24K
min0%
max23.16%
average3.98%
median0.52%
std6.09%